mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.07 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.07 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
0.51 |
0.07 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.07 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.08 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.08 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.08 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.08 |